Cellbyte
PrivateLast Round
Seed
Nov 18, 2025
Total Funding Raised
$2.75M
Company Overview
Cellbyte is a technology company that has developed an AI-driven platform to assist pricing and market access (P&MA) teams in the pharmaceutical industry. The platform uses natural language processing, allowing users to analyze complex clinical, regulatory, HTA (Health Technology Assessment), and pricing data to streamline the process of launching new drugs. By enabling users to ask questions in natural language, Cellbyte aims to reduce research time from days to seconds. The company was co-founded by Daniel Moreira, Felix Steinbrenner, and Samuel Moreira. It is backed by Y Combinator and focuses on major European markets with plans to expand.
Sector
Enterprise Software
Verticals
Vertical SaaS, Healthcare Analytics, Medical AI, NLP & Conversational AI, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellbyte Comps
Public and private peers based on sector, stage, and business model.
Cellbyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2025 |
Cellbyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Pace Ventures | Seed |
| Y Combinator | Seed |
| Springboard Health Angels | Seed |
| Frontline Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
$2.75M raised in Seed round.
- Oct 1, 2025
Company is profitable with double-digit month-over-month growth.
Cellbyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellbyte's valuation, stock price, and market status.
